64410-44-2Relevant articles and documents
Antiviral Immunotropic Agent for the Treatment of Acute Respiratory Viral Infections
-
Paragraph 0058; 0063, (2019/11/05)
The proposed methods of treatment pertain to medicine, in particular pharmacology, and concerns the application of a nasal medicinal composition containing hexapeptide tyrosyl-D-alanyl-glycyl-phenylalanyl-leucyl-arginine or its pharmaceutically acceptable
Amino acids and peptides. XXIV. Preparation and antinociceptive effect of [D-Ala2, (N-Me)Phe4]enkephalin analog-poly(ethylene glycol) hybrids
Maeda,Kawasaki,Takahashi,Nakao,Kaneto
, p. 1859 - 1863 (2007/10/02)
Hybrids of amino-poly(ethylene glycol) (aPEG) and [D-Ala2,(N-Me)Phe4]enkephalin analogs, H-Tyr-D-Ala-Gly-(Me)Phe-aPEG, H-Tyr-D-Ala-Gly-(Me)Phe-Leu-aPEG and H-Tyr-D-Ala-Gly-(Me)Phe-D-Leu-aPEG, were prepared by the solution method and
Novel Analogues of Enkephalin: Identification of Functional Groups Required for Biological Activity
Gorin, Fredric A.,Balasubramanian, T. M.,Cicero, Theodore J.,Schwietzer, John,Marshall, Garland R.
, p. 1113 - 1122 (2007/10/02)
Novel tri- and tetrapeptide analogues of enkephalin, in conjunction with earlier structure-activity data, confirm that chemical substituents present in the first and fourth residues of enkephalin are required for in vitro biological activity.A class of ar